¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"minimal brain dysfunction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
¿µ¹® blood-brain barrier(BBB) ÇÑ±Û Ç÷³úÀ庮
¼³¸í   
  ³ú¿Í Ã´¼ö¿¡´Â Ç÷·ù·ÎºÎÅÍ ¾î¶² ¹°ÁúÀÌ À¯ÀԵǴ °ÍÀ» ¸·´Â À庮ÀÌ´Ù. À̰ÍÀº ³ú¿Í Ã´¼ö¿¡ Á¸ÀçÇϴ ¸ð¼¼Ç÷°üÀÇ Åõ°ú¼ºÀÌ ºñ±³Àû ´Ù¸¥ ¸ð¼¼Ç÷°üÀÇ Åõ°ú¼ºº¸´Ù ¶³¾îÁö±â ¶§¹®ÀÌ´Ù.
¿µ¹® blood-brain barrier ÇÑ±Û Ç÷¾×³úÀ庮
¼³¸í   
  Ç÷¾×À¸·ÎºÎÅÍ ³ú·Î´Â ÁöÁú¿ëÇØ¼ºÀÌ ³ôÀº ¾à¹°¹Û¿¡ ÀÌÇàµÇÁö ¾Ê´Â´Ù. ¼ö¿ë¼ºÀÇ ¾à¹°À» ³ú·Î ÀÌÇàµÇÁö ¾Ê°Ô Çϰí Àִ °ÍÀÌ Ç÷¾×³úÀ庮À̸砳úÀÇ ¸ð¼¼Ç÷°ü ³»ÇǼ¼Æ÷, ¸ð¼¼Ç÷°ü ÁÖÀ§ÀÇ ¼¼Æ÷°¡ À庮ÀÌ µÇ°í ÀÖ´Ù. ¹°Áú±³È¯Àº ¼öµ¿È®»ê¿¡ ÀÇÇØ ÀÌ·ç¾îÁöÁö¸¸, ³úÀÇ »ý¸®Àû È°µ¿¿¡ ÇÊ¿äÇÑ ¹°ÁúÀº ÀÌ¿ÂÇüÀ̶󵵠´ãü¸¦ ÅëÇØ ÀÌÇàµÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • minimal blocking concentration
    ÃÖ¼ÒÂ÷´Ü³óµµ
  • minimal change disease
    ¹Ì¼¼º¯È­º´
  • minimal current gradient
    ÃÖ¼ÒÀü·ù±â¿ï±â, ÃÖ¼ÒÀü·ù°æ»ç
  • minimal effective analgesic concentration
    ÃÖ¼ÒÈ¿°úÁøÅë³óµµ
  • minimal effective dose
    ÃÖ¼ÒÀ¯È¿·®
  • minimal erythema dose
    ÃÖ¼ÒÈ«¹Ý¼±·®
  • minimal identifiable odor
    ÃÖ¼ÒÀνij¿»õ, ÃÖ¼ÒºÐÇØÃë°¢
  • minimal infecting dose
    ÃÖ¼Ò°¨¿°¿ë·®
  • minimal inhibitory concentration
    ÃÖÀú¾ïÁ¦³óµµ
  • minimal lethal dose
    1. ÃÖ¼ÒÄ¡»ç·® 2. ÃÖ¼ÒÄ¡»ç¼±·®
  • minimal stimulus
    ÃÖ¼ÒÀÚ±Ø
  • minimal tension line
    ÃÖ¼ÒÀå·Â¼±
  • minimal visible angle
    Ãּҽð¢
  • minimal volition period
    ÃÖ¼Ò¼öÃà±â
  • acute brain syndrome
    ±Þ¼º³úÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • brain infarct
    ³ú°æ»ö
  • brain map
    ³úÁÂÇ¥µµ
  • brain stem
    ³úÁÙ±â
  • brain vesicle
    ³ú¼ÒÆ÷
  • brain death syndrome
    ³ú»çÁõÈıº
  • brain function mapping
    ³ú±â´ÉÁöµµÈ­
  • brain natriuretic peptide
    ³ú³ªÆ®·ýÀÌ´¢ÆéƼµå
  • brain stem evoked potential
    ³úÁÙ±âÀ¯¹ßÀüÀ§
  • olfactory brain
    Èİ¢³ú
  • minor brain damage
    °æµµ³ú¼Õ»ó
  • elective brain irradiation
    ¿¹¹æ³úÁ¶»ç
  • hypoxic brain injury
    Àú»ê¼Ò³ú¼Õ»ó
  • organic brain syndrome
    ±âÁú³úÁõÈıº
  • primary brain vesicles
    ÀÏÂ÷³úÆ÷
  • minimal visible angle
    Ãּҽð¢
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • prolapse of brain
    ³úÅ»(ÃâÁõ)(Òà÷­(õóñø))
  • prosencephalon =fore brain
    Àü³ú.
  • prosencephalon =fore brain
    Àü³ú.
  • radiation brain necrosis
    ¹æ»ç¼±³ú±«»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • neuromuscular dysfunction
    ½Å°æ±Ù ±â´ÉºÎÀü, ¡­±â´ÉÀå¾Ö
  • perceptual disorder =p. dysfunction
    Áö°¢Àå¾Ö(ò±ÊÆî¡äô).
  • placental dysfunction syndrome
    Źݱâ´ÉºÎÀüÁõÈıº(¡­Ñ¦ÒöÝÕîïñøý¦ÏØ).
  • placental dysfunction syndrome
    Źݱâ´ÉºÎÀüÁõÈıº(÷ÃÚïѦÒöÝÕîïñøý¦ÏØ)
  • sexual dysfunction
    ¼º±â´ÉÀå¾Ö
  • sexual dysfunction
    ¼º±â´É°ï¶õ
  • somatoform autonomic dysfunction
    ½ÅüÇü ÀÚÀ²½Å°æ±â´É°ï¶õ
  • tube dysfunction, eustachian
    À̰ü±â´ÉºÎÀü
  • vesical dysfunction
    ¹æ±¤±â´ÉÀÌ»ó
  • voiding dysfunction
    ¹è´¢±â´ÉÀÌ»ó
  • minimal air
    ÃÖ¼Ò°ø±â.
  • minimal angle resolution
    ÃÖ¼Ò°¢ºÐÇØ´É.
  • minimal auditory threshold
    ÃÖ¼Ò°¡Ã»¿ªÄ¡(õÌ á³Ê¦ôéÚÊö·).
  • minimal auditory threshold
    ÃÖ¼Ò°¡Ã»¿ªÄ¡
  • minimal bactericidal concentration (MBC)
    »ì±ÕÃÖ¼Ò³óµµ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MPDS mandibular pain dysfunction syndrome; myofascial pain dysfunction syndrome
NBD neurogenic bladder dysfunction; no brain damage
MIC maternal and infant care; medical intensive care; Medical Interfraternity Conference; microscopy; mi...
MBD Minimal Brain Dysfuction
BBB   1) Bundle Branch Block
  2) Blood Brain Barrier - Blood Brain Barrier
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
LVSD Left ventricular systolic dysfunction
MGD Meibomian gland dysfunction
MND Minor neurological dysfunction
MODS Multi Organ Dysfunction Syndrome
MOD Multiple Organ Dysfunction
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • pain-dysfunction syndrome
    µ¿Åë ±â´É Àå¾Ö ÁõÈıº
  • painful dysfunction
    µ¿Åë ±â´ÉÀå¾Ö
  • placental dysfunction syndrome
    ÅÂ¹Ý ±â´É ºÎÀü ÁõÈıº
    ŹÝÀÇ º¯¼º¿¡ ÀÇÇÑ Å¹ÝÀÇ ¿µ¾çÀå¾Ö¿Í Àú»ê¼ÒÁõ. »ó´çÈ÷ ÁøÇàµÈ °æ¿ì¿¡ ¼ÕÅé, ÇǺΠ¹× ÅÂÁö´Â ¼±È²»öÀ¸·Î, Á¦´ë´Â Ȳ·Ï»öÀ¸·Î Âø»öµÈ´Ù.
  • polyglandular dysfunction
    ´Ù¼±¼º ±â´É ÀÌ»ó
  • renal dysfunction
    ½Å ±â´É Àå¾Ö
  • temporomandibular dysfunction sysndrome
    ÃøµÎÇÏ¾Ç ±â´É Àå¾Ö ÁõÈıº
  • temporomandibular joint dysfunction
    ÃøµÎÇϾǰüÀý ±â´É Àå¾Ö, ¾Ç°üÀý ±â´É ÀÌ»ó
    ÃøµÎÇϾǰüÀýÀÇ ºñÁ¤»óÀûÀÌ°í ºÒ¿ÏÀüÇϸç Àå¾Ö°¡ ÀÖ´Â ±â´É.
  • temporomandibular pain-dysfunction syndrome
    ÃøµÎÇÏ¾Ç µ¿Åë Àå¾Ö ÁõÈıº
  • TMJ dysfunction syndrome
    ¾Ç°üÀý ±â´É Àå¾Ö ÁõÈıº, ÃøµÎÇϾǰüÀý Àå¾Ö ÁõÈıº
  • TMJ pain dysfunction syndrome
    ¾Ç°üÀý µ¿Åë ±â´É Àå¾Ö ÁõÈıº
  • acute brain disorder
    ±Þ¼º ³úÀå¾Ö
  • atypical or mixed organic brain syndrome
    ºñÁ¤Çü ³»Áö È¥ÇÕÇü ±âÁú¼º ³ú ÁõÈıº
  • blood-brain barrier
    Ç÷³ú À庮
    ³ú¿Í ô¼ö¿¡´Â Ç÷·ù·ÎºÎÅÍ ¾î¶² ¹°ÁúÀÌ À¯ÀԵǴ °ÍÀ» ¸·´Â À庮ÀÌ Á¸ÀçÇϰí À̰ÍÀ» Ç÷³ú À庮À̶ó ÇÑ´Ù. À̰ÍÀº ³ú¿Í ô¼ö¿¡ Á¸ÀçÇÏ´Â ¸ð¼¼Ç÷°üÀÇ Åõ°ú¼ºÀÌ ´Ù¸¥ ¸ð¼¼Ç÷°ü¿¡ ºñÇØ ¶³¾îÁö±â ¶§¹®ÀÌ´Ù.
  • brain abscess
    ³ú ³ó¾ç
    ³ú ³ó¾çÀº ³ú ½ÇÁú³»¿¡ ¿©·¯ Á¾·ùÀÇ ¼¼±Õ, Áø±Õ, ¿øÃæ·ùµéÀÇ °¨¿°¿¡ ÀÇÇÏ¿© ¹ß»ýµÇ´Â ±¹ÇÑµÈ È­³ó¼º ÁúȯÀÌ´Ù. 1. ¿øÀÎ : ¿©·¯ Á¾·ùÀÇ ¼¼±Õ, Áø±Õ, È¿¸ð±Õ, ±â»ýÃæ µîÀÌ ³ú ³ó¾çÀ» ÀÏÀ¸Å³ ¼ö ÀÖÀ¸¸ç, °ú°Å¿¡´Â ¿¬¼â»ó ±¸±Õ, Æ÷µµ»ó ±¸±Õ, Àå³»±Õ, Æó·Å ±¸±Õ µîÀÌ °¡Àå ÈçÇÑ ¿øÀαÕÀ̾úÀ¸³ª ±Ù·¡¿¡ ¿Í¼­ Ç×»ýÁ¦ÀÇ ±¤¹üÀ§ÇÑ »ç¿ë, ¸é¿ª°áÇÌÁõ ȯÀÚÀÇ Áõ°¡ µîÀ¸·Î ¼Ò °£±Õ, Çø±â¼º ¿¬¼â»ó ±¸±ÕÀÌ °¡Àå ÈçÇÑ ¿øÀαÕÀ¸·Î µÇ¾úÀ¸¸ç, Nocardia±Õ, Áø±Õ, ±â»ýÃæÀÇ ºóµµµµ ³ô¾ÆÁö°í ÀÖ´Ù. °¨¿° °æ·Î¸¦ º¸¸é ÁßÀÌ¿°À̳ª ºÎºñµ¿¿°¿¡¼­ Á÷Á¢ ¶Ç´Â ³ú ÇÇÁú, ³ú°æ¸·ÀÇ Á¤¸ÆÀ» ÅëÇÏ¿© °¨¿°µÇ°Å³ª µÎºÎÀÇ °üÅë»óÀ̳ª µÎºÎ ¼ö¼úÈÄÀÇ ÇÕº´ÁõÀ¸·Î Ç÷·ù¸¦ ÅëÇÑ ÆÐÇ÷¼º »öÀüÀ» ÅëÇÏ¿© ¶Ç´Â ¾Æ±Þ¼º ¼¼±Õ¼º ½É³»¸·¿°À̳ª ¼±Ãµ¼º ½ÉÀ庴 ±×¸®°í ¸é¿ª±â´ÉÀÌ ÀúÇÏµÈ °æ¿ì¿¡ ÁÖ·Î ¹ß»ýÇϸç, »ó´ç¼ö¿¡¼­´Â °¨¿° °æ·Î¸¦ ¸ð¸£´Â °æ¿ìµµ ÀÖ´Ù. 2. Áõ»ó : ´ëºÎºÐÀÇ ³ú ³ó¾çÀº 20¼¼ ÀÌÀü¿¡ ¹ß»ýµÇ´Âµ¥ ±× ÀÌÀ¯´Â ÀÌ ¿¬·É ±º¿¡¼­ ÁßÀÌ¿°À̳ª Ãà³óÁõÀÇ ºóµµ°¡ ³ôÀ¸¸ç, ¼±Ãµ¼º ½ÉÀ庴¿¡ ±âÀÎµÈ ³ú ³ó¾çÀÌ ÁÖ·Î ¼Ò¾Æ±â¿¡ ¹ß»ýµÇ±â ¶§¹®ÀÌ´Ù. 3´ë 2¿¡¼­ 2´ë 1ÀÇ ºñÀ²·Î ³²ÀÚ¿¡¼­ ¸¹ÀÌ ¹ß»ýÇÑ´Ù. ÁßÀÌ¿°¿¡¼­ ¹ß»ýµÈ °æ¿ì¿¡´Â ÁÖ·Î ÃøµÎ¿±¿¡ ¹ß»ýµÇ¸ç °¡²û ÃøµÎ¿±À̳ª ÅÍŰ¾È¿¡µµ »ý±ä´Ù. Ç÷¾×À» ÅëÇÏ¿© ÀüÀÌµÈ °æ¿ì°¡ ÃÖ±Ù Áõ°¡µÇ°í Àִµ¥ ´ëºÎºÐ ´Ù¹ß¼ºÀ̰ųª ±íÀº °÷¿¡ À§Ä¡Çϰí óÀ½ Áø´Ü ½Ã °æ°è°¡ È®½ÇÄ¡ ¾ÊÀº Ư¡ÀÌ ÀÖ¾î ¿¹Èİ¡ ÁÁÁö ¾ÊÀº ÆíÀÌ´Ù. ÁÖ Áõ»óÀ̳ª ½Å°æÇÐÀû ÀÌ»ó Á¤µµ´Â ³ó¾çÀÇ ºÎÀ§, Å©±â, º´¼ÒÀÇ ¼ö, ¿øÀαÕÀÇ µ¶¼º, ÁÖº¯ ³ú ºÎÁ¾ÀÇ Á¤µµ, °¨¿°¿¡ ´ëÇÑ ¼÷ÁÖÀÇ ¹ÝÀÀ µî¿¡ µû¶ó ´Ù¸£¸ç ÀϹÝÀûÀ¸·Î ³ú Á¶Á÷ÀÇ ÆÄ±«¿Í Á¾±« È¿°ú¿¡ µû¶ó µÎ°³°­ ³»¾ÐÀÇ »ó½Â°ú ±¹¼Ò¼º ½Å°æÇÐÀû Àå¾Ö¸¦ ÀÏÀ¸Å²´Ù. Áõ»ó ¹ßÇö°ú Áø´Ü±îÁöÀÇ ±â°£Àº 75%¿¡¼­ 2ÁÖ À̳»ÀÌ¸ç °¡Àå ÈçÇÑ Áõ»óÀº Á¡Â÷ ½ÉÇØÁö´Â µÎÅëÀ¸·Î 70-95%ÀÇ È¯ÀÚ¿¡¼­ ³ªÅ¸³ª¸ç ÁÖ·Î ¿À½É°ú ±¸Å並 µ¿¹ÝÇÑ´Ù. ¹ßÀÛÀÌ 30-50%ÀÇ È¯ÀÚ¿¡¼­ ³ªÅ¸³ª°í ¹Ý¼öÀÇ È¯ÀÚ¿¡¼­ ¹Ì¿­ÀÌ ³ªÅ¸³ªÁö¸¸ 39µµ ÀÌ»óÀÇ °í¿­Àº µå¹°´Ù. ¼Ò³ú ³ó¾çÀÇ °æ¿ì¿¡´Â Çö±âÁõÀ̳ª ÇöÈÆÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù. ÀÔ¿ø½Ã ¾à ¹Ý¼öÀÇ È¯ÀÚ¿¡¼­´Â ¹ß¿­ µîÀÇ Àü½Å Áõ»óÀÌ ³ªÅ¸³ª¸ç µÎ°³°­ ³»¾ÐÀÇ »ó½ÂÀ¸·Î 23-50%¿¡¼­ À¯µÎ ºÎÁ¾À» º¼ ¼ö ÀÖ´Ù. ÀÔ¿ø ½Ã¿¡ ¹Ý¼ö À̻󿡼­ ÀÇ½Ä Àå¾Ö°¡ ÀÖÀ¸¸ç °æÇÑ ÀǽÄÀÇ Àå¾Ö·ÎºÎÅÍ È¥¼ö »óűîÁö ¿©·¯ Á¤µµ·Î ³ªÅ¸³­´Ù. óÀ½ ÀǽÄÀÇ Á¤µµ°¡ ȯÀÚÀÇ ¿¹ÈÄ¿¡¼­ °¡Àå Áß¿äÇÏ´Ù. ³ú ÇÇÁúÀ̳ª ³ú ÇÇÁú ÇϺÎÀÇ Æ¯Á¤ÇÑ ºÎÀ§ÀÇ ¼Õ»óÀ¸·Î ±¹¼Ò¼º ½Å°æÇÐÀû Àå¾Ö¸¦ ÀÏÀ¸Å³ ¼ö ÀÖÀ¸¸ç ¹Ý½Å ¸¶ºñ, ¾ð¾îÀå¾Ö, ½Ã¾ß °á¼Õ µîÀ» ÈçÈ÷ º¼ ¼ö ÀÖ´Ù. ¼Ò³ú ³ó¾çÀÇ °æ¿ì¿¡´Â ¼öÆò¼º ¾È±¸ ÁøÅÁ
  • brain center
    ´ë³ú ÁßÃß
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
ventricular dysfunction A condition in which the ventricles of the heart exhibit a decreased functionality.
(12 Dec 1998)
ventricular dysfunction, left A condition in which the left ventricle of the heart exhibits a decreased functionality. This decreased function could lead to congestive heart failure or myocardial infarction, among other cardiovascular diseases. Diagnostic measurements that indicate this condition include a diminished ejection fraction and a depressed level of motility of the left ventricular wall.
(12 Dec 1998)
ventricular dysfunction, right A condition in which the right ventricle of the heart exhibits a decreased functionality. This decreased function could lead to congestive heart failure or myocardial infarction, among other cardiovascular diseases. Diagnostic measurements that indicate this condition include a diminished ejection fraction and a depressed level of motility of the right ventricular wall.
(12 Dec 1998)
phagocyte bactericidal dysfunction Disorders in which phagocytic cells cannot kill ingested bacteria; characterised by frequent recurring infection with formulation of granulomas.
(12 Dec 1998)
phagocyte dysfunction Disorder in which the ability of the phagocyte to engulf and ingest particles may be impaired.
(05 Mar 2000)
phagocytic dysfunction disorders immunodeficiency Suppression in number or function of phagocytic cells such as in chronic granulomatous disease.
Synonym: phagocytic dysfunction disorders immunodeficiency.
Origin: L. Phagedaena, Gr Phago, To eat.
(05 Mar 2000)
phagocytic dysfunction immunodeficiency Suppression in number or function of phagocytic cells such as in chronic granulomatous disease.
Synonym: phagocytic dysfunction disorders immunodeficiency.
Origin: L. Phagedaena, Gr Phago, To eat.
(05 Mar 2000)
placental dysfunction 1. Denoting faulty development or ripening; often connoting structural and/or functional abnormalities.
2. In obstetrics, denoting an infant whose birth weight is inappropriately low for its gestational age.
3. Immature development of the placenta so that normal function does not occur.
Synonym: placental dysfunction.
(05 Mar 2000)
placental dysfunction syndrome <syndrome> Foetal malnutrition and hypoxia resulting from impaired transfer of oxygen and various nutritive materials from mother to foetus.
(05 Mar 2000)
constitutional hepatic dysfunction Mild jaundice due to increased amounts of unconjugated bilirubin in the plasma without evidence of liver damage, biliary obstruction, or haemolysis; thought to be due to an inborn error of metabolism in which the excretion of bilirubin by the liver is defective, ascribed to decreased conjugation of bilirubin as a glucuronide or impaired uptake of hepatic bilirubin.
Synonym: benign familial icterus, constitutional hepatic dysfunction, Gilbert's disease, Gilbert's syndrome, Hebra's disease.
(05 Mar 2000)
constitutional liver dysfunction An inherited disorder that affects the way bilirubin in handled by the liver. Thought to be due to an inborn error of bilirubin metabolism.
Symptoms include mild jaundice, weakness, fatigue, nausea and abdominal pain.
(27 Sep 1997)
myofacial pain-dysfunction syndrome <syndrome> Dysfunction of the masticatory apparatus related to spasm of the muscles of mastication precipitated by occlusal dysharmony or alteration in vertical dimension of the jaws, and exacerbated by emotional stress; characterised by pain in the preauricular region, muscle tenderness, popping noise in the temporomandibular joint, and limitation of jaw motion.
Synonym: temporomandibular joint pain-dysfunction syndrome.
(05 Mar 2000)
hereditary peroneal nerve dysfunction <neurology> A slowly progressive genetic disorder characterised by muscle atrophy in the feet and the legs, progressing to the hands and arms, due to a disorder involving the destruction of nerves (degeneration of the myelin sheath).
Other features include foot drop and a slapping gait. There is no specific treatment for this disorder.
(27 Sep 1997)
psychosexual dysfunction Sexual dysfunction, a disturbance of sexual functioning, e.g., impotence, premature ejaculation, anorgasmia, presumed to be of psychological rather than physical aetiology.
(05 Mar 2000)
sphincter of Oddi dysfunction Structural or functional abnormality of the sphincter of Oddi that interferes with bile drainage.
Synonym: biliary dyskinesia.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • brain truster
    Á¤Ã¥ °í¹®
  • brain truster
    Á¤Ã¥°í¹®
  • brain wave
    ³úÆÄ;¿µ°¨;¹¦¾È
  • brain work
    Á¤½Å³ëµ¿ÀÚ
  • electronic brain
    ÀüÀÚ µÎ³ú(ÀüÀÚ °è»ê±â µûÀ§)
  • mechanical brain
    Àΰø µÎ³ú 
  • right-brain
    ¿ì³ú
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á